Free Newsletter
AMA won't ban industry-funded education
Pharma marketers can sigh with relief. The American Medical Association won't be banning industry-funded CME this year, at least. At the association's annual meeting, delegates opted against a proposal to bar drugmakers from sponsoring residencies and fellowships, live or online CME, speakers' bureaus, travel and lodging, and the like. "Industry support of professional education has raised concerns that threaten the integrity of medicine’s educational function," the proposal stated.
Apparently, there were some concerns about a sponsorship ban, too. So the controversial measure, which would also have banned industry gifts and detailing at med schools, will get further review instead.
- read the Pharmalot item
Related Articles:
Arms twisted, pharma promises CME disclosure
Med schools tight with drugmakers
NC teaching hospital nixes drug-sample handouts
Comments
By Anonymous | Posted 2:07pm | June 17, 2008
This is quite positive for a change. Maybe the AMA should focus on the few bad apples, weed them out so the rest can benefit from the outstanding programs offered by industry. Not everything Industry does is tainted and most of the Med Ed offered is excellent.
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: